fluorouracil has been researched along with Radiodermatitis in 42 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Radiodermatitis: A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Newer radiation techniques, and the application of continuous 5-FU exposure during radiation therapy using oral capecitabine may improve the treatment of anal cancer." | 5.17 | Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. ( Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Dewit, L; Schellens, JH, 2013) |
| "Definitive chemoradiation with concurrent 5-fluorouracil (5-FU)/mitomycin C (MMC) is an effective treatment for localized anal cancer, but it is associated with significant acute long-term treatment-related toxicity." | 3.91 | Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study. ( Adams, J; Allen, JN; Baglini, C; Ben-Josef, E; Blaszkowsky, LS; Clark, JW; DeLaney, TF; Drapek, LC; Hong, TS; Jiang, W; Metz, JM; Murphy, JE; Parikh, AR; Plastaras, JP; Ryan, DP; Wo, JY; Yeap, BY, 2019) |
| " The authors report a case of radiation recall resulting from an interaction between radiation delivered during a fluoroscopically guided hepatic chemoembolization for treatment of metastatic carcinoid tumor and the oral chemotherapeutic agents capecitabine and temozolomide administered 7 weeks later." | 3.80 | Radiation recall after a transarterial hepatic chemoembolization. ( Sands, MJ; Wunderle, KA, 2014) |
| "A 61-year-old man, with a tuberous sclerosis, experienced severe acute reactions during a concomitant chemoradiotherapy regimen after 22Gy and one cycle of 5-fluorouracil-cisplatinum." | 3.79 | [Hypersensitivity to radiation therapy in a patient with tuberous sclerosis: biological considerations about a clinical case]. ( Baruch-Hennequin, V; Duchemain, B; Duchemann, B; Hennequin, C; Quero, L; Rivera, S; Wong, S, 2013) |
| "We believe this case to be the second case of radiation recall presenting as diffuse gastritis in a patient receiving capecitabine after previous treatment with XRT." | 3.73 | Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. ( Black, G; Diasio, R; Johnson, M; Russo, S; Saif, MW, 2006) |
| " We evaluated the toxicity and efficacy of a Hypofractionated and intensively Accelerated RT regimen supported with amifostine Cytoprotection (HypoARC) in a cohort of 72 high-risk breast cancer patients treated with modified mastectomy or conservative surgery and FEC (5-fluorouracil/epirubicin/cyclophosphamide) chemotherapy." | 3.71 | Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. ( Frangiadaki, C; Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Koukourakis, MI; Kouroussis, C; Retalis, G; Sivridis, E, 2002) |
| "Rectal squamous cell carcinoma is a rare tumour; it management should be based on anal curative and conservative intent chemoradiation." | 2.53 | [Rectal squamous cell carcinoma treatment: Retrospective experience in two French university hospitals, review and proposals]. ( Bosset, JF; Huguet, F; Loganadane, G; Schernberg, A; Servagi-Vernat, S; Touboul, E, 2016) |
| "Grade 3-4 neutropenia was seen in 10/23 patients (43%)." | 1.46 | PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer. ( Beer, J; Bodis, S; Oehler, C; Vlachopoulou, V; von Moos, R; Zimmermann, M; Zwahlen, DR, 2017) |
| "To investigate the association between polymorphisms of DNA repair genes and xenobiotic with acute adverse effects in locally advanced rectal cancer patients treated with neoadjuvant radiochemotherapy." | 1.46 | Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy. ( Agolli, L; Borro, M; Bracci, S; De Sanctis, V; Di Nardo, F; Enrici, RM; Falco, T; Gentile, G; Maglio, M; Minniti, G; Nicosia, L; Osti, MF; Simmaco, M; Valeriani, M, 2017) |
| "Radiotherapy is a common approach for treating squamous cell carcinoma (SCC) of the oropharynx." | 1.43 | Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma. ( Clerici, E; Cozzi, L; D'Agostino, G; Fogliata, A; Franceschini, D; Franzese, C; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S, 2016) |
| "The treatment of anal cancer is based on concomitant radiotherapy and chemotherapy and is associated with a nonnegligible rate of local severe toxicities that can strongly impair the quality of life." | 1.39 | Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. ( Benezery, K; Doyen, J; Follana, P; Francois, E; Gal, J; Gérard, JP; Hannoun-Levi, JM; Ortholan, C, 2013) |
| "Chemoradiation for anal cancer yields effective tumor control, but is associated with significant acute toxicity." | 1.38 | Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. ( Blaszkowsky, LS; Coen, JJ; Hartshorn, K; Hong, TS; Kachnic, LA; Kwak, EL; Ryan, DP; Tsai, HK; Willins, JD, 2012) |
| "Tumour histology was squamous cell carcinoma in 74% of the cases." | 1.37 | [Radiotherapy for cutaneous cancers with xeroderma pigmentosum]. ( Abdelmoula, M; Bahri, M; Ben Salah, H; Daoud, J; Frikha, M; Turki, H, 2011) |
| "All of them had stage IV, unresectable squamous cell carcinoma of the pharynx and they received continuous bid radiotherapy (two daily fractions of 1." | 1.31 | [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center]. ( Bensadoun, RJ; Chauvel, P; Courdi, A; Dassonville, O; Demard, F; Ettore, F; Falewee, MN; Lagrange, JL; Magné, N; Marcy, PY; Milano, G; Pivot, X; Poissonnet, G; Santini, J; Schneider, M; Vallicioni, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (26.19) | 29.6817 |
| 2010's | 28 (66.67) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Sauter, M | 1 |
| Lombriser, N | 1 |
| Bütikofer, S | 1 |
| Keilholz, G | 1 |
| Kranzbühler, H | 1 |
| Heinrich, H | 1 |
| Rogler, G | 1 |
| Vavricka, SR | 1 |
| Misselwitz, B | 1 |
| Zimmermann, M | 1 |
| Beer, J | 1 |
| Bodis, S | 1 |
| von Moos, R | 1 |
| Vlachopoulou, V | 1 |
| Zwahlen, DR | 1 |
| Oehler, C | 1 |
| Dalenc, F | 1 |
| Ribet, V | 1 |
| Rossi, AB | 1 |
| Guyonnaud, J | 1 |
| Bernard-Marty, C | 1 |
| de Lafontan, B | 1 |
| Salas, S | 1 |
| Ranc Royo, AL | 1 |
| Sarda, C | 1 |
| Levasseur, N | 1 |
| Massabeau, C | 1 |
| Levecq, JM | 1 |
| Dulguerova, P | 1 |
| Guerrero, D | 1 |
| Sibaud, V | 1 |
| Wo, JY | 1 |
| Plastaras, JP | 1 |
| Metz, JM | 1 |
| Jiang, W | 1 |
| Yeap, BY | 1 |
| Drapek, LC | 1 |
| Adams, J | 1 |
| Baglini, C | 1 |
| Ryan, DP | 2 |
| Murphy, JE | 1 |
| Parikh, AR | 1 |
| Allen, JN | 1 |
| Clark, JW | 1 |
| Blaszkowsky, LS | 2 |
| DeLaney, TF | 1 |
| Ben-Josef, E | 1 |
| Hong, TS | 2 |
| Deenen, MJ | 1 |
| Dewit, L | 1 |
| Boot, H | 1 |
| Beijnen, JH | 1 |
| Schellens, JH | 1 |
| Cats, A | 1 |
| Doyen, J | 1 |
| Benezery, K | 1 |
| Follana, P | 1 |
| Ortholan, C | 2 |
| Gérard, JP | 1 |
| Hannoun-Levi, JM | 1 |
| Gal, J | 1 |
| Francois, E | 1 |
| Gao, YH | 1 |
| An, X | 1 |
| Sun, WJ | 1 |
| Cai, J | 1 |
| Cai, MY | 1 |
| Kong, LH | 1 |
| Lin, JZ | 1 |
| Liu, GC | 1 |
| Tang, JH | 1 |
| Wu, XJ | 1 |
| Chen, G | 1 |
| Pan, ZZ | 1 |
| Ding, PR | 1 |
| Call, JA | 1 |
| Prendergast, BM | 1 |
| Jensen, LG | 1 |
| Ord, CB | 1 |
| Goodman, KA | 1 |
| Jacob, R | 1 |
| Mell, LK | 1 |
| Thomas, CR | 1 |
| Jabbour, SK | 1 |
| Miller, RC | 1 |
| Wunderle, KA | 1 |
| Sands, MJ | 1 |
| Troussier, I | 1 |
| Huguet, F | 2 |
| Servagi-Vernat, S | 2 |
| Benahim, C | 1 |
| Khalifa, J | 1 |
| Darmon, I | 1 |
| Krebs, L | 1 |
| Dejean, C | 1 |
| Fenoglietto, P | 1 |
| Vieillot, S | 1 |
| Bensadoun, RJ | 2 |
| Thariat, J | 2 |
| Osti, MF | 1 |
| Nicosia, L | 1 |
| Agolli, L | 1 |
| Gentile, G | 1 |
| Falco, T | 1 |
| Bracci, S | 1 |
| Di Nardo, F | 1 |
| Minniti, G | 1 |
| De Sanctis, V | 1 |
| Valeriani, M | 1 |
| Maglio, M | 1 |
| Borro, M | 1 |
| Simmaco, M | 1 |
| Enrici, RM | 1 |
| Voong, KR | 1 |
| Rashid, A | 1 |
| Crane, CH | 2 |
| Minsky, BD | 1 |
| Krishnan, S | 1 |
| Yao, JC | 1 |
| Wolff, RA | 2 |
| Skibber, JM | 1 |
| Feig, BW | 1 |
| Chang, GJ | 1 |
| Das, P | 1 |
| Kim, BH | 1 |
| Kim, HK | 1 |
| Shin, JK | 1 |
| Hong, HJ | 1 |
| Lee, JH | 1 |
| Park, H | 1 |
| Hwang, SG | 1 |
| Rim, KS | 1 |
| Franzese, C | 1 |
| Fogliata, A | 1 |
| Franceschini, D | 1 |
| Clerici, E | 1 |
| D'Agostino, G | 1 |
| Navarria, P | 1 |
| Mancosu, P | 1 |
| Tomatis, S | 1 |
| Cozzi, L | 1 |
| Scorsetti, M | 1 |
| Schernberg, A | 1 |
| Loganadane, G | 1 |
| Touboul, E | 1 |
| Bosset, JF | 1 |
| Bondiau, PY | 1 |
| Bahadoran, P | 1 |
| Lallement, M | 1 |
| Birtwisle-Peyrottes, I | 1 |
| Chapellier, C | 1 |
| Chamorey, E | 1 |
| Courdi, A | 2 |
| Quielle-Roussel, C | 1 |
| Ferrero, JM | 1 |
| Oikawa, H | 1 |
| Nakamura, R | 1 |
| Nakasato, T | 1 |
| Nishimura, K | 1 |
| Sato, H | 1 |
| Ehara, S | 1 |
| Buiret, G | 1 |
| Combe, C | 1 |
| Favrel, V | 1 |
| Pommier, P | 1 |
| Martin, L | 1 |
| Ecochard, R | 1 |
| Fayette, J | 1 |
| Tartas, S | 1 |
| Ramade, A | 1 |
| Céruse, P | 1 |
| Damast, S | 1 |
| Ho, AY | 1 |
| Montgomery, L | 1 |
| Fornier, MN | 1 |
| Ishill, N | 1 |
| Elkin, E | 1 |
| Beal, K | 1 |
| McCormick, B | 1 |
| Shueng, PW | 1 |
| Wu, LJ | 1 |
| Chen, SY | 1 |
| Hsiao, CH | 1 |
| Tien, HJ | 1 |
| Cheng, PW | 1 |
| Kuo, YS | 1 |
| Chen, YJ | 1 |
| Chen, CA | 1 |
| Hsieh, PY | 1 |
| Hsieh, CH | 1 |
| Yu, Z | 1 |
| Luo, W | 1 |
| Zhou, QC | 1 |
| Zhang, QH | 1 |
| Kang, DH | 1 |
| Liu, MZ | 1 |
| Mallik, S | 1 |
| Gupta, S | 1 |
| Munshi, A | 1 |
| Clavel, S | 1 |
| Fortin, B | 1 |
| Després, P | 1 |
| Donath, D | 1 |
| Soulières, D | 1 |
| Khaouam, N | 1 |
| Charpentier, D | 1 |
| Bélair, M | 1 |
| Guertin, L | 1 |
| Nguyen-Tan, PF | 1 |
| Wolff, HA | 1 |
| Raus, I | 1 |
| Jung, K | 1 |
| Schüler, P | 1 |
| Herrmann, MK | 1 |
| Hennies, S | 1 |
| Vorwerk, H | 1 |
| Hille, A | 1 |
| Hess, CF | 1 |
| Christiansen, H | 1 |
| Rades, D | 1 |
| Kronemann, S | 1 |
| Meyners, T | 1 |
| Bohlen, G | 1 |
| Tribius, S | 1 |
| Kazic, N | 1 |
| Schroeder, U | 1 |
| Hakim, SG | 1 |
| Schild, SE | 1 |
| Dunst, J | 1 |
| Kachnic, LA | 1 |
| Tsai, HK | 1 |
| Coen, JJ | 1 |
| Hartshorn, K | 1 |
| Kwak, EL | 1 |
| Willins, JD | 1 |
| Isaev, PA | 1 |
| Medvedev, VS | 1 |
| Pasov, VV | 1 |
| Semin, DIu | 1 |
| Derbugov, DN | 1 |
| Pol'kin, VV | 1 |
| Terekhov, OV | 1 |
| Ben Salah, H | 1 |
| Bahri, M | 1 |
| Turki, H | 1 |
| Abdelmoula, M | 1 |
| Frikha, M | 1 |
| Daoud, J | 1 |
| Partl, R | 1 |
| Richtig, E | 1 |
| Kapp, KS | 1 |
| Robertson, B | 1 |
| Shepherd, L | 1 |
| Abratt, RP | 1 |
| Hunter, A | 1 |
| Goldberg, P | 1 |
| Aguilar-Ponce, JL | 1 |
| Granados-García, M | 1 |
| Cruz López, JC | 1 |
| Maldonado-Magos, F | 1 |
| Alvarez-Avitia, MA | 1 |
| Arrieta, O | 1 |
| González-Ramírez, I | 1 |
| Lara-Cruz, G | 1 |
| Martinez-Juárez, I | 1 |
| Medina-Santillan, R | 1 |
| Castillo-Hernández, C | 1 |
| De la Garza-Salazar, J | 1 |
| Duchemann, B | 1 |
| Duchemain, B | 1 |
| Wong, S | 1 |
| Baruch-Hennequin, V | 1 |
| Rivera, S | 1 |
| Quero, L | 1 |
| Hennequin, C | 1 |
| Camidge, R | 1 |
| Price, A | 1 |
| Saif, MW | 1 |
| Black, G | 1 |
| Johnson, M | 1 |
| Russo, S | 1 |
| Diasio, R | 1 |
| Sroa, N | 1 |
| Bartholomew, DA | 1 |
| Magro, CM | 1 |
| Huang, CJ | 1 |
| Hou, MF | 1 |
| Lin, SD | 1 |
| Chuang, HY | 1 |
| Huang, MY | 1 |
| Fu, OY | 1 |
| Lian, SL | 1 |
| Sanfilippo, NJ | 1 |
| Skibber, J | 1 |
| Feig, B | 1 |
| Abbruzzese, JL | 1 |
| Curley, S | 1 |
| Vauthey, JN | 1 |
| Ellis, LM | 1 |
| Hoff, P | 1 |
| Brown, TD | 1 |
| Cleary, K | 1 |
| Wong, A | 1 |
| Phan, T | 1 |
| Janjan, NA | 1 |
| Magné, N | 1 |
| Pivot, X | 1 |
| Marcy, PY | 1 |
| Chauvel, P | 1 |
| Dassonville, O | 1 |
| Poissonnet, G | 1 |
| Vallicioni, J | 1 |
| Ettore, F | 1 |
| Falewee, MN | 1 |
| Milano, G | 1 |
| Santini, J | 1 |
| Lagrange, JL | 1 |
| Schneider, M | 1 |
| Demard, F | 1 |
| Koukourakis, MI | 1 |
| Giatromanolaki, A | 1 |
| Kouroussis, C | 1 |
| Kakolyris, S | 1 |
| Sivridis, E | 1 |
| Frangiadaki, C | 1 |
| Retalis, G | 1 |
| Georgoulias, V | 1 |
| Ortmann, E | 1 |
| Hohenberg, G | 1 |
| Badr el Din, A | 1 |
| Coibion, M | 1 |
| Guenier, C | 1 |
| Nogaret, JM | 1 |
| Lorent, I | 1 |
| Van Houtte, P | 1 |
| Tueni, E | 1 |
| Mattheiem, W | 1 |
| Scherer, E | 1 |
| Rassow, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal[NCT01858025] | Early Phase 1 | 25 participants (Actual) | Interventional | 2013-07-31 | Active, not recruiting | ||
| A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent C[NCT04085250] | Phase 2 | 264 participants (Actual) | Interventional | 2019-11-28 | Active, not recruiting | ||
| A Multicenter and Prospective Clinical Trial of Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma[NCT04522050] | Phase 1 | 65 participants (Anticipated) | Interventional | 2018-10-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fluorouracil and Radiodermatitis
| Article | Year |
|---|---|
[Rectal squamous cell carcinoma treatment: Retrospective experience in two French university hospitals, review and proposals].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcin | 2016 |
Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cisplatin; | 2006 |
3 trials available for fluorouracil and Radiodermatitis
| Article | Year |
|---|---|
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; | 2018 |
Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; C | 2013 |
Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2009 |
37 other studies available for fluorouracil and Radiodermatitis
| Article | Year |
|---|---|
Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; F | 2020 |
PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chem | 2017 |
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Topics: Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamou | 2019 |
Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Brac | 2013 |
Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; China; | 2014 |
Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cape | 2016 |
Radiation recall after a transarterial hepatic chemoembolization.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoid Tumor; | 2014 |
[Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
Topics: Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell | 2015 |
Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Chemoradiothera | 2017 |
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptotheci | 2017 |
[Fluoroscopy-induced Subacute Radiation Dermatitis in Patient with Hepatocellular Carcinoma].
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluoroscopy; Fluorouracil; Gamma Rays; Humans; | 2016 |
Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2016 |
Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report--improvement of locoregional control of oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2009 |
A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brea | 2010 |
Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined | 2010 |
[Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Fl | 2009 |
Memoirs of differential radiation doses: Gemcitabine induced radiation recall.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin | 2010 |
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squa | 2011 |
High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 2011 |
Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 2011 |
Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squam | 2012 |
[Early-onset radiation complications and tissue damage in the treatment of head and neck tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; | 2010 |
[Radiotherapy for cutaneous cancers with xeroderma pigmentosum].
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachyth | 2011 |
Calling attention to radiation recall reactions. Simultaneous occurrence of a Recall Dermatitis after CMF application in two separate sites irradiated 10 years apart.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 2012 |
Treatment of carcinoma of the anal canal at Groote Schuur Hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neo | 2012 |
Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2013 |
[Hypersensitivity to radiation therapy in a patient with tuberous sclerosis: biological considerations about a clinical case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplat | 2013 |
Radiation recall dermatitis may represent the Koebner phenomenon.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine | 2002 |
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Deoxycytidine; Dihyd | 2006 |
Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Comb | 2006 |
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combined Mo | 2001 |
[Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2001 |
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Topics: Adult; Aged; Alkaline Phosphatase; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Breas | 2002 |
Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuv | 2002 |
Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1989 |
[Basic principles of percutaneous radiotherapy in cervical lymph node metastases].
Topics: Carcinoma, Squamous Cell; Cesium Isotopes; Cobalt Isotopes; Electrons; Fluorouracil; Head and Neck N | 1971 |